Effect of Renal Impairment on Enpatoran Pharmacokinetics
Clinical trial NCT06589713 · COMPLETED
Trial details
- NCT number
- NCT06589713
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2026-04-13
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.